Supplementary information

From the following article:

Molecular basis for sunitinib efficacy and future clinical development

Sandrine Faivre, George Demetri, William Sargent & Eric Raymond

Nature Reviews Drug Discovery 6, 734-745 (September 2007)

doi:10.1038/nrd2380

Supplementary information S1 (table)

Summary of adverse events in the Phase III placebo-controlled GIST study (4/2 schedule of treatment administration).

Download Browser Plugins and Other Applications

Compressed Stuff files

Compressed Zip files

Systems Biology Markup Language files (SMBL)

Chemical Markup language files (CML)